Sutro Biopharma Inc. (STRO)
11.01
-0.53 (4.59%)
Upcoming Events
Latest Headlines
Sutro Biopharma doses first patient in Phase 1 trial of STRO-006 ADC
October 21, 2026 8:02 AM - StreetInsider
Sutro Biopharma Announces First Patient Dosed in Phase 1 Trial of STRO-006, a Next-Generation ITGB6-Targeting ADC, in Advanced Solid Tumors
October 21, 2026 8:01 AM - Globe NewsWire
H.C. Wainwright Reiterates Buy Rating on Sutro Biopharma (STRO)
October 16, 2026 8:08 AM - StreetInsider
Sutro Biopharma Announces Participation at the 17th Annual World ADC Conference
October 12, 2026 8:00 AM - Globe NewsWire
Wells Fargo Assumes Sutro Biopharma (STRO) at Overweight
September 30, 2026 6:23 AM - StreetInsider
Sutro Biopharma names new SVP of business development
September 29, 2026 8:01 AM - StreetInsider
Sutro Biopharma Appoints Lucas Donigian as Senior Vice President, Business Development
September 29, 2026 8:00 AM - Globe NewsWire
Form 4 SUTRO BIOPHARMA, INC. For: Sep 18 Filed by: Gerber Hans-Peter
September 22, 2026 4:09 PM - SEC Filing
Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
September 1, 2026 9:07 AM - StreetInsider
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: PERCEPTIVE ADVISORS LLC
August 14, 2026 5:24 PM - SEC Filing
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: Point72 Asset Management, L.P.
August 14, 2026 4:17 PM - SEC Filing
Sutro Biopharma (STRO) PT Lowered to $34 at Citizens on Q2 Revenue Miss
August 13, 2026 4:13 AM - StreetInsider
Sutro Biopharma Inc. (STRO) Misses Q2 EPS by 13c
August 12, 2026 7:59 AM - StreetInsider
Form 10-Q SUTRO BIOPHARMA, INC. For: Jun 30
August 12, 2026 7:31 AM - SEC Filing
Form 8-K SUTRO BIOPHARMA, INC. For: Aug 12
August 12, 2026 7:19 AM - SEC Filing
Sutro Biopharma posts Q2 loss, reports early STRO-004 trial data
August 12, 2026 7:01 AM - StreetInsider
Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study
August 12, 2026 7:00 AM - Globe NewsWire
Stifel Starts Sutro Biopharma (STRO) at Buy
August 6, 2026 4:07 PM - StreetInsider
Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: BlackRock, Inc.
July 30, 2026 11:20 AM - SEC Filing
Full Article List
